Kluster Kepakaran/ Cluster of Expertise :
Kesihatan dan Perubatan Termaju,
Biografi/ Biography :
Dr. Kok-Yong Chin adalah seorang pensyarah kanan di Jabatan Farmakologi, Fakulti Perubatan, Universiti Kebangsaan Malaysia. Minat penyelidikannya merangkumi epidemiologi kesihatan tulang, penuaan lelaki, metabolisme tulang, dan penggunaan vitamin E dalam merawat penyakit muskuloskeletal. Beliau adalah pengarang/bersama pengarang lebih daripada 220 artikel jurnal. Indeks h beliau kini berada pada 39, menurut Scopus. Beliau memenangi Anugerah Penyelidik Muda di Persidangan Ke-32 Persatuan Farmakologi dan Fisiologi Malaysia pada tahun 2018, Persidangan Ke-5 Persekutuan Osteoporosis Asia pada tahun 2017, dan Persidangan International Conference on Advances in Medical Science pada tahun 2015. Beliau juga merupakan wakil Malaysia di Mesyuarat Pemenang Nobel Lindau ke-65 pada tahun 2015. Kini, beliau berkhidmat sebagai editor akademik untuk Journal of Tropical Life Science, editor bersekutu untuk BMC Public Health dan Frontiers in Endocrinology, serta ahli lembaga editorial untuk Medicine & Health. Beliau disenaraikan sebagai 2% saintis yang paling banyak dirujuk oleh Elsevier pada tahun 2021-2023.
Dr Kok-Yong Chin is a senior lecturer at the Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia. His research interests include the epidemiology of bone health, male ageing, bone metabolism and the use of vitamin E in treating musculoskeletal diseases. He is the author/coauthor of more than 220 journal articles. His h-index currently stands at 39, according to Scopus. He won the Young Investigator Award at the 32nd Malaysian Society of Pharmacology and Physiology in 2018, the 5th Asian Federation of Osteoporosis Society Meeting in 2017, and the 1st International Conference of Advances in Medical Science in 2015. He was also a representative of Malaysia at the 65th Lindau Nobel Laureate Meeting in 2015. He currently serves as an academic editor of the Journal of Tropical Life Science, associate editor of BMC Public Health and Frontiers in Endocrinology, and an editorial board member of Medicine & Health. He is listed as the top 2% most cited scientist by Elsevier in 2021-2023.
leong xin fang, shadisvaaran saminathan, chin kok yong, shahida mohd said. (2026). annatto tocotrienol: a dual-action innovation for oral and cardiovascular health. - 7th international invention & innovation in dentistry exhibition (iiidentex) 2026. .
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
kok-yong chin. (2026). vitamin k2 as a bone protective bioactive against osteoporosis and fragility fracture. - advances in biochemistry in health and d. 437 - 458.
sophia ogechi ekeuku, kumeshini sukalingam, mohd fahami nur azlina, fairus ahmad, kok-yong chin and elvy suhana mohd ramli. (2026). kelulut honey modulates skeletal health and bone-related molecular markers in rats fed a high-carbohydrate and high-fat diet. - life. 1 - 20.
sok kuan wong, sarah sharul sham, kok-yong chin, nur liyana mohammed yusof, toh leong tan, evelyn yi wen chau, aireen zamhot, amirudin sanip, amir muharram. (2026). association of glycaemic control with inflammatory response and organ dysfunction severity in sepsis patients. - 9th international biotechnology symposium (sb9). .
sophia ogechi ekeuku, kumeshini sukalingam, mohd fahami nur azlina, fairus ahmad, kok-yong chin and elvy suhana mohd ramli. (2026). kelulut honey modulates skeletal health and bone-related molecular markers in rats fed a high-carbohydrate and high-fat diet. - life. 1 - 20.
xia ji, yuanzhong wang, zefan zhang, kok-lun pang, xiong khee cheong, norliza muhammad, kok-yong chin. (2026). in utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies. - frontiers in endocrinology. 1 - 15.
shabbir adnan shakir, juen kiem tan, and kok-yong chin. (2026). neuroprotective effects and mechanisms of carvacrol and thymol in alzheimer’s disease: a scoping review. - pharmaceuticals. 1 - 33.
kok-yong chin, kok-lun pang, chun-wai mai and alessandro salatino. (2026). editorial: nutraceuticals modulation for oxidative stress in disease and health: volume ii. - frontiers in pharmacology. 1 - 3.
kok-yong chin and kok-lun pang. (2026). editorial: natural products in bone health and disease: mechanisms, therapeutics, and clinical potential. - frontiers in endocrinology. 1 - 3.
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
mohammed farhan abed al salman, sophia ogechi ekeuku and kok-yong chin. (2026). autophagy in testicular physiology and male fertility: mechanisms, dysregulation, and translational opportunities. - malaysian journal of pathology. 257 - 266.
yuanzhong wang, li lian goh, kok-yong chin. (2026). d-galactose-induced osteoporosis in rodents—model development, skeletal characteristics, and optimal dosing regimens: a scoping review. - biomolecules and biomedicine. 1913 - 1933.
yuanzhong wang, guiju chen, qin wang, xia ji, xiaodong ma, and kok-yong chin. (2026). unveiling the osteoprotective potential of morinda officinalis: a scoping review of current evidence. - natural product communications. 1 - 18.
yuanzhong wang, guiju chen, zaifu zhou, wenjian zhao, sok kuan wong, yuxia wang, kok-yong chin. (2026). male osteoporosis: a comprehensive review of treatment approaches in modern pharmacotherapy and traditional chinese medicine interventions. - endocrine, metabolic & immune disorders - drug targets. 1 - 22.
wenjian zhao, weizheng zhang, kok-yong chin, xiaodong ma, hashwin singh tejpal singh, sophia ogechi ekeuku, yuanzhong wang, xia ji, yang guo, sok kuan wong, norliza muhammad, teh rohaila jamil, saharuddin ahmad. (2026). adiposity indices and bone health amongst malaysian adults: evidence from a cross-sectional study. - experimental and therapeutic medicine. 1 - 8.
sophia ogechi ekeuku, kumeshini sukalingam, mohd fahami nur azlina, fairus ahmad, kok-yong chin and elvy suhana mohd ramli. (2026). kelulut honey modulates skeletal health and bone-related molecular markers in rats fed a high-carbohydrate and high-fat diet. - life. 1 - 20.
mohammed farhan abed al salman, sophia ogechi ekeuku and kok-yong chin. (2026). autophagy in testicular physiology and male fertility: mechanisms, dysregulation, and translational opportunities. - malaysian journal of pathology. 257 - 266.
xia ji, yuanzhong wang, zefan zhang, kok-lun pang, xiong khee cheong, norliza muhammad, kok-yong chin. (2026). in utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies. - frontiers in endocrinology. 1 - 15.
shabbir adnan shakir, juen kiem tan, and kok-yong chin. (2026). neuroprotective effects and mechanisms of carvacrol and thymol in alzheimer’s disease: a scoping review. - pharmaceuticals. 1 - 33.
fairus ahmad, chin kok yong, khairun-nisa hashim. (2024). sesudu madu kelulut merahmati kesihatan. - . .
ima nirwana soelaiman, chin kok yong, wong sok kuan. (2019). serba-serbi mengenai kesihatan tulang dan penyakit osteoporosis. - . 140.
kok-yong chin. (2026). vitamin k2 as a bone protective bioactive against osteoporosis and fragility fracture. - advances in biochemistry in health and d. 437 - 458.
kok-yong chin. (2024). chapter 8 recent progress on the skeletal research of tocotrienol. - advances in biochemistry in health. 163-180.
kok-lun pang, sophia ogechi ekeuku, kok-yong chin. (2024). decellularised natural cancellous trabecular bone scaffold in tissue engineering. - . 191-211.
norazlina mohamed, chin kok yong. (2024). kaedah penuaan sihat secara saintifik. - . 11 - 13.
norzana abdul ghafar, norliza muhammad, yogeswaran lokanathan, chin kok yong & wong sok kuan. (2024). penuaan dan penyakit degeneratif. - . 14 - 26.
prof. dr. ima nirwana soelaiman, prof. madya dr. zuliskandar ramli, prof. madya dr. elvy suhana mohd. ramli, prof. madya dr. chin kok yong, dr. fairus ahmad, dr. wong sok kuan, dr. atika md. ashar. (2026). ukm kaji kesihatan tulang manusia prasejarah. - kosmo!. .
prof. dr. ima nirwana soelaiman, prof. madya dr. zuliskandar ramli, prof. madya dr. elvy suhana mohd. ramli, prof. madya dr. chin kok yong, dr. fairus ahmad, dr. wong sok kuan, dr. atika md. ashar. (2026). sains buka 'jendela masa' ribuan tahun. - sinar harian. .
ima nirwana soelaiman, zuliskandar ramli, elvy suhana mohd. ramli, chin kok yong, fairus ahmad, wong sok kuan, atika md. ashar. (2026). rangka prasejarah gua chawan sepadan manusia moden. - utusan malaysia. .
prof. dr. ima nirwana soelaiman, muhammad zubair kassim, prof. madya dr. chin kok yong. (2026). montage for officiating ceremony. - . .
fairus ahmad, chin kok yong, khairun-nisa hashim. (2024). sesudu madu kelulut merahmati kesihatan. - . .
leong xin fang, shadisvaaran saminathan, chin kok yong, shahida mohd said. (2026). annatto tocotrienol: a dual-action innovation for oral and cardiovascular health. - 7th international invention & innovation in dentistry exhibition (iiidentex) 2026. .
sok kuan wong, sarah sharul sham, kok-yong chin, nur liyana mohammed yusof, toh leong tan, evelyn yi wen chau, aireen zamhot, amirudin sanip, amir muharram. (2026). association of glycaemic control with inflammatory response and organ dysfunction severity in sepsis patients. - 9th international biotechnology symposium (sb9). .
sok kuan wong, sarah sharul sham, kok-yong chin, nur liyana mohammed yusof, toh leong tan, evelyn yi wen chau, aireen zamhot, amirudin sanip, amir muharram. (2026). association of glycaemic control with inflammatory response and organ dysfunction severity in sepsis patients. - 9th international biotechnology symposium (sb9). .
prof. dr. ima nirwana soelaiman, prof. madya dr. zuliskandar ramli, prof. madya dr. elvy suhana mohd. ramli, prof. madya dr. chin kok yong, dr. fairus ahmad, dr. wong sok kuan, dr. atika md. ashar. (2026). ukm kaji kesihatan tulang manusia prasejarah. - kosmo!. .
prof. dr. ima nirwana soelaiman, prof. madya dr. zuliskandar ramli, prof. madya dr. elvy suhana mohd. ramli, prof. madya dr. chin kok yong, dr. fairus ahmad, dr. wong sok kuan, dr. atika md. ashar. (2026). sains buka 'jendela masa' ribuan tahun. - sinar harian. .
| Geran / Grant | Kolaborator / Collaborator | Status |
|---|---|---|
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | malaysian palm oil board (mpob) | 96.5% (2021-11-11 sehingga 2026-12-15) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | excelvite sdn. bhd | 96.5% (2021-11-11 sehingga 2026-12-15) |
| THE EFFECT OF PALM TOCOTRIENOL RICH FRACTION ON ALCOHOLIC FATTY LIVER DISEASE (AFLD): A PHASE II CLINICAL TRIAL | hovid berhad | 96.5% (2021-11-11 sehingga 2026-12-15) |
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | malaysian palm oil board (mpob) | 92.7% (2022-11-29 sehingga 2027-01-30) |
| TOCOTRIENOL AS A SENOLYTIC AGENT: A PHASE 2 CLINICAL TRIAL | davos life science sdn bhd | 92.7% (2022-11-29 sehingga 2027-01-30) |
BASIC MEDICAL SCIENCES
Osteoporosis
Pengalaman / Experience : tahun/years(s)
BASIC MEDICAL SCIENCES
Animal models of osteoporosis, osteoarthritis
Pengalaman / Experience : 5 tahun/years(s)
PHARMACOLOGY
Osteoporosis
Pengalaman / Experience : tahun/years(s)
PHARMACOLOGY
Osteoporosis and Bone Metabolism
Pengalaman / Experience : 5 tahun/years(s)
MRDCS